Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

rFgl2-treated CD32b<sup>+</sup>M2 macrophages effectively inhibits cardiac transplant rejection in mice.

Immunobiology·2026
Same author

Platelet RIP2 Limits Dense Granule Release and Thrombosis via DOCK8-Cdc42.

Arteriosclerosis, thrombosis, and vascular biology·2026
Same author

High-concentration estradiol promotes platelet activation and thrombosis through Src-ADP axis.

Translational research : the journal of laboratory and clinical medicine·2026
Same author

Theoretical Analysis and Numerical Simulation of Ejection Demolding Process Parameters for Large Cylindrical Helical Gears After Die Forging.

Materials (Basel, Switzerland)·2026
Same author

Case Report: Synchronous colorectal adenocarcinomas with discordant mismatch repair status: a case of lynch-like syndrome and serrated pathway association.

Frontiers in oncology·2026
Same author

Optimization of Parameters of Block-Shaped Support Tooth Structure Using Orthogonal Experimental Design in Laser Powder Bed Fusion.

Materials (Basel, Switzerland)·2026

Related Experiment Video

Updated: May 15, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Aspirin Induces platelet apoptosis.

Lili Zhao1, Weilin Zhang, Mengxing Chen

  • 1School of Biological Science and Medical Engineering, Beijing University of Aeronautics and Astronautics , Beijing , China.

Platelets
|January 11, 2013
PubMed
Summary

Aspirin induces platelet apoptosis, a programmed cell death, through caspase-3 activation. This finding clarifies a potential mechanism behind aspirin

More Related Videos

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NF&#954;B Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Related Experiment Videos

Last Updated: May 15, 2026

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NF&#954;B Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Aspirin is a widely used medication with known side effects, including bleeding risks.
  • The precise mechanisms underlying aspirin's side effects are not fully understood.
  • Recent studies suggest aspirin can induce apoptosis (programmed cell death) in various cell types.

Purpose of the Study:

  • To investigate whether aspirin induces apoptosis specifically in platelets.
  • To elucidate the molecular pathways involved in aspirin-induced platelet apoptosis.

Main Methods:

  • Platelets were incubated with varying doses of aspirin.
  • Assays included measurement of mitochondrial transmembrane potential (ΔΨm), phosphatidylserine (PS) exposure, and caspase-3 activity.
  • The effects of caspase inhibitor z-VAD-fmk and cyclooxygenase inhibitor indomethacin were evaluated.

Main Results:

  • Aspirin dose-dependently induced ΔΨm depolarization and PS exposure in platelets.
  • Aspirin activated caspase-3, a key enzyme in apoptosis.
  • Platelet volume reduction and ΔΨm depolarization were inhibited by z-VAD-fmk, while PS exposure was not affected.

Conclusions:

  • Aspirin induces platelet apoptosis through a mechanism involving caspase-3 activation.
  • This study provides insights into the cellular effects of aspirin on platelets.
  • Understanding aspirin-induced platelet apoptosis may contribute to managing its clinical risks.